Forskningsradar
← Alla bevakningsområden

Life Sciences

1711 artiklar · sida 65 av 69

🇸🇪 Endast svenska
3.7

A major international patient registry reveals that transthyretin amyloidosis—a rare protein disorder—presents with overlapping cardiac and neurological symptoms in a third of patients, a pattern rarely recognized a decade ago. The finding could reshape how doctors diagnose and treat the disease, potentially accelerating approval pathways for therapies targeting this larger patient subgroup.EN

2024-01-01 · Cardiology and Therapy · , , et al.
3.7

Researchers have developed a genetic tool to identify which herring population is caught in the Norwegian Sea, where multiple stocks mix together. The breakthrough could end years of biased fish counts that have skewed quota decisions and potentially masked overfishing of vulnerable populations.EN

2024-01-01 · Marine Ecology Progress Series · , , et al.
3.7

Researchers using genetic analysis found that prolonged screen time increases the risk of multiple gastrointestinal conditions—from acid reflux to Crohn's disease—independent of overall weight. The finding could reshape how health insurers, employers, and public health agencies approach workplace wellness and sedentary behavior prevention.EN

2024-01-01 · EBioMedicine · , , et al.
3.7

An international consortium has launched ENIGMA-Chronic Pain, pooling brain scans from thousands of patients worldwide to identify physical changes in pain sufferers' brains. The findings could transform how doctors diagnose and treat chronic pain—a condition affecting hundreds of millions globally and costing healthcare systems billions annually.EN

2024-01-01 · Pain · , , et al.
3.7

Researchers sequenced 17 pairs of identical twins where one developed schizophrenia or bipolar disorder and the other didn't—finding rare genetic variants unique to the affected twin. The discovery suggests that mutations occurring after conception, not just inherited DNA, may trigger psychosis, potentially reshaping how psychiatrists understand and diagnose these disorders.EN

2024-01-01 · Translational Psychiatry · , , et al.
3.7

Researchers identified five biological pathways linking body weight to colorectal cancer, including inflammation and insulin resistance. The findings could help drugmakers and health systems target high-risk obese patients with precision interventions before cancer develops, potentially reducing one of the world's deadliest cancers.EN

2024-01-01 · International Journal of Epidemiology · , , et al.
3.7

Researchers found that waist-to-hip ratios adjusted for body shape—not traditional BMI—are better predictors of colorectal cancer in both men and women. The discovery could reshape how insurers, employers, and health systems assess cancer risk and target prevention programs.EN

2024-01-01 · International Journal of Obesity · , , et al.
3.7

Researchers found that over one-third of women with incontinentia pigmenti—a rare X-linked genetic disorder—develop antibodies that disable their natural antiviral defenses, leaving them exposed to life-threatening infections. The discovery identifies a new mechanism linking genetic thymus damage to autoimmune disease and could redirect vaccine and immunotherapy strategies for at-risk populations.EN

2024-01-01 · Journal of Experimental Medicine · , , et al.
3.7

A rare genetic eye disease called choroideremia stems from defects in how cells transport melanin and build blood vessels in the back of the eye, new research shows. The findings could guide development of gene therapies and explain why patients progressively lose vision, potentially opening doors for earlier intervention strategies.EN

2024-01-01 · Biochimica et Biophysica Acta - Molecular Basis of Disease · , , et al.
3.7

Researchers have successfully reprogrammed natural enzymes to accept modified ingredients, producing novel oxygenated molecules that could accelerate drug development. The breakthrough reveals how subtle chemical tweaks can unlock enzyme flexibility—a finding with direct implications for pharmaceutical manufacturing and biotech efficiency.EN

2024-01-01 · Biochemistry · , , et al.
3.7

Researchers identified eight previously unknown genes linked to epilepsy using a rare seizure-prone pig breed, potentially accelerating development of new treatments. The finding challenges the dominance of rodent models in epilepsy research and could reshape how pharmaceutical companies test experimental seizure drugs before human trials.EN

2024-01-01 · Neurogenetics · , , et al.
3.7

A large genetic analysis found no evidence that ghrelin—a hormone that regulates appetite—influences colorectal cancer development, contradicting earlier conflicting research. The finding could redirect cancer prevention efforts and reshape how pharmaceutical companies approach appetite-related drug development for patients at elevated disease risk.EN

2024-01-01 · Cancer Epidemiology, Biomarkers and Prevention · , , et al.
3.7

Researchers have adapted an advanced imaging method to map cerebrospinal fluid movement throughout the brain and spine in 3D, opening diagnostic possibilities for neurological disorders tied to impaired waste clearance. The technique could transform how doctors diagnose and monitor conditions ranging from Alzheimer's to hydrocephalus, with implications for pharmaceutical development and clinical trial design.EN

2024-01-01 · NMR in Biomedicine · , , et al.
3.7

Researchers using machine learning on brain imaging from nearly 5,400 people found they could classify depression only slightly better than a coin flip—even with the largest dataset ever assembled. The findings suggest that current neuroimaging approaches alone won't enable automated depression diagnosis, reshaping expectations for AI-driven mental health screening and clinical adoption timelines.EN

2024-01-01 · Scientific Reports · , , et al.
3.7

Computational modeling has become essential for understanding enzyme mechanisms and designing better drugs, according to a new review in ACS Omega. The ability to simulate enzyme behavior computationally is accelerating drug discovery and enzyme engineering—potentially cutting development costs and timelines for pharmaceutical companies.EN

2024-01-01 · ACS Omega · , , et al.
3.7

Researchers have cut the computational time needed to evaluate multiple traits in breeding programs by replacing complex statistical models with a simpler approach. The method could accelerate genetic selection across agriculture and forestry, where breeders currently face delays when assessing dozens of characteristics simultaneously.EN

2024-01-01 · G3 · , , et al.
3.7

Scientists have published an updated reference guide mapping nearly 1,800 drug targets and 6,000 drug interactions—a resource designed to help researchers and companies identify promising treatment avenues. The catalog, which focuses on G protein-coupled receptors and other major therapeutic pathways, provides a citable snapshot of current pharmacological knowledge that could accelerate drug development timelines.EN

2023-01-01 · British Journal of Pharmacology · , , et al.
3.7

Researchers discovered a previously unknown RNA molecule that drives inflammation in blood vessels, a hallmark of atherosclerosis and aortic aneurysms. The finding could open new diagnostic and therapeutic targets for cardiovascular disease, which remains the leading cause of death globally and carries enormous healthcare costs.EN

2023-01-01 · BIORXIV · , , et al.
3.7

Researchers have identified the genetic switches that control whether birds migrate or stay put—pinpointing three genes that explain how species rapidly colonize new territories then diversify locally. The discovery could inform conservation strategies for endangered birds and offer insights into how populations adapt to environmental change.EN

2023-01-01 · Journal of Evolutionary Biology · , , et al.
3.7

Researchers identified a common genetic variation that increases colorectal cancer susceptibility by 35% and predicts survival in Swedish patients. The finding could enable early screening of high-risk individuals and inform treatment decisions, potentially improving outcomes for one of the world's most common cancers.EN

2023-01-01 · Nucleosides, Nucleotides & Nucleic Acids · , , et al.
3.7

Researchers have developed RegiSTORM, a tool that corrects a persistent alignment problem in multi-color super-resolution microscopy—a technique crucial for mapping biological interactions. The fix could accelerate drug development and disease research by making microscopy data more reliable and easier to analyze.EN

2023-01-01 · BMC Bioinformatics · , , et al.
3.7

Researchers have identified that a bacterium called Rothia mucilaginosa triggers cancer cell growth in a rare form of Hodgkin lymphoma, potentially explaining why some patients develop the disease. The discovery could lead to new diagnostics and targeted therapies, reshaping how this cancer is prevented and treated.EN

2023-01-01 · Haematologica · , , et al.
3.7

Paleontologists have identified two previously unknown paddlefish species in a mass graveyard from 66 million years ago, offering rare insight into how freshwater ecosystems responded to the asteroid impact. The discovery at North Dakota's Tanis Site demonstrates that aquatic food chains restructured within hours of the catastrophe—a finding with implications for understanding ecosystem resilience to sudden environmental shocks.EN

2023-01-01 · Journal of Paleontology · , , et al.
3.7

Researchers assembled a high-quality genome for the spurge hawkmoth, revealing 29 chromosomes and stable gene organization across species. The work provides a genetic blueprint for understanding how moths diverge and adapt—insights that could inform pest management strategies and broader evolutionary biology research with commercial applications.EN

2023-01-01 · BMC Genomics · , , et al.
3.7

Scientists sequencing DNA from Pakistani families with spinocerebellar disorders—progressive neurological diseases affecting movement and cognition—found nine genetic variants causing the conditions, six of them previously unknown. The findings could enable earlier diagnosis and inform drug development strategies for rare neurological diseases that disproportionately affect consanguineous populations.EN

2023-01-01 · Genes · , , et al.